{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:17:14Z","timestamp":1719879434040},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.7759\/cureus.63577","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T11:49:54Z","timestamp":1719834594000},"source":"Crossref","is-referenced-by-count":0,"title":["Bisphosphonate-Induced Orbital Cellulitis in a Patient With Suspected Parathyroid Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Teodora","family":"McKenna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic E","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinson","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Korda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Una","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/science.165.3899.1262","article-title":"Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo","volume":"165","author":"Fleisch H","year":"1969","unstructured":"Fleisch H, Russell RG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science. 1969, 165:1262-4. 10.1126\/science.165.3899.1262","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.01.014","article-title":"Pharmacology of bisphosphonates","volume":"49","author":"Cremers S","year":"2011","unstructured":"Cremers S, Papapoulos S. Pharmacology of bisphosphonates. Bone. 2011, 49:42-9. 10.1016\/j.bone.2011.01.014","journal-title":"Bone"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935821","article-title":"A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia","volume":"28","author":"Tonon CR","year":"2022","unstructured":"Tonon CR, Silva TA, Pereira FW, et al.. A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia. Med Sci Monit. 2022, 28:e935821. 10.12659\/MSM.935821","journal-title":"Med Sci Monit"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner W","year":"2016","unstructured":"Goldner W. Cancer-related hypercalcemia. J Oncol Pract. 2016, 12:426-32. 10.1200\/JOP.2016.011155","journal-title":"J Oncol Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v17i1.10176","article-title":"Orbital inflammation caused by aminobisphosphonates","volume":"17","author":"Gonzalez Barlatay J","year":"2022","unstructured":"Gonzalez Barlatay J, Pagano Boza C, Hernandez Gauna GV, Premoli JE. Orbital inflammation caused by aminobisphosphonates. J Ophthalmic Vis Res. 2022, 17:118-22. 10.18502\/jovr.v17i1.10176","journal-title":"J Ophthalmic Vis Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2009.02.023","article-title":"Intraocular pressure change in orbital disease","volume":"54","author":"Nassr MA","year":"2009","unstructured":"Nassr MA, Morris CL, Netland PA, Karcioglu ZA. Intraocular pressure change in orbital disease. Surv Ophthalmol. 2009, 54:519-44. 10.1016\/j.survophthal.2009.02.023","journal-title":"Surv Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.anorl.2012.01.002","article-title":"Parathyroid carcinoma: a difficult histological diagnosis","volume":"129","author":"Rodriguez C","year":"2012","unstructured":"Rodriguez C, Nad\u00e9ri S, Hans C, Badoual C. Parathyroid carcinoma: a difficult histological diagnosis. Eur Ann Otorhinolaryngol Head Neck Dis. 2012, 129:157-9. 10.1016\/j.anorl.2012.01.002","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6329.20.04306-X","article-title":"Bisphosphonate-associated osteonecrosis of the jaw","volume":"70","author":"Ferreira Jr LH Jr","year":"2021","unstructured":"Ferreira Jr LH Jr, Mendon\u00e7a Jr KD Jr, Chaves de Souza J, et al.. Bisphosphonate-associated osteonecrosis of the jaw. Minerva Dent Oral Sci. 2021, 70:49-57. 10.23736\/S2724-6329.20.04306-X","journal-title":"Minerva Dent Oral Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215118000324","article-title":"Bisphosphonate-induced osteonecrosis of the ear canal: our experience and a review of the literature","volume":"132","author":"McCadden L","year":"2018","unstructured":"McCadden L, Leonard CG, Primrose WJ. Bisphosphonate-induced osteonecrosis of the ear canal: our experience and a review of the literature. J Laryngol Otol. 2018, 132:372-4. 10.1017\/S0022215118000324","journal-title":"J Laryngol Otol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.1226","article-title":"Bisphosphonate-associated adverse events","volume":"8","author":"Papapetrou PD","year":"2009","unstructured":"Papapetrou PD. Bisphosphonate-associated adverse events. Hormones (Athens). 2009, 8:96-110. 10.14310\/horm.2002.1226","journal-title":"Hormones (Athens)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2022.0094","article-title":"Ocular side effects of bisphosphonates: a review of the literature","volume":"39","author":"Chartrand NA","year":"2023","unstructured":"Chartrand NA, Lau CK, Parsons MT, Handlon JJ, Ronquillo YC, Hoopes PC, Moshirfar M. Ocular side effects of bisphosphonates: a review of the literature. J Ocul Pharmacol Ther. 2023, 39:3-16. 10.1089\/jop.2022.0094","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/11206721221125022","article-title":"Osteoporosis, bisphosphonates, and ocular inflammation","volume":"33","author":"Nouraeinejad A","year":"2022","unstructured":"Nouraeinejad A. Osteoporosis, bisphosphonates, and ocular inflammation. Eur J Ophthalmol. 2022, 33:637-42. 10.1177\/11206721221125022","journal-title":"Eur J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S180058","article-title":"Orbital compartment syndrome: an update with review of the literature","volume":"13","author":"McCallum E","year":"2019","unstructured":"McCallum E, Keren S, Lapira M, Norris JH. Orbital compartment syndrome: an update with review of the literature. Clin Ophthalmol. 2019, 13:2189-94. 10.2147\/OPTH.S180058","journal-title":"Clin Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4989","article-title":"Stones, bones, groans, and psychic moans: primary hyperparathyroidism presenting as surgical emergency","volume":"11","author":"Saleem M","year":"2019","unstructured":"Saleem M, Iftikhar H. Stones, bones, groans, and psychic moans: primary hyperparathyroidism presenting as surgical emergency. Cureus. 2019, 11:e4989. 10.7759\/cureus.4989","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan AA","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, et al.. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017, 28:1-19. 10.1007\/s00198-016-3716-2","journal-title":"Osteoporos Int"},{"key":"ref16","article-title":"Primary hyperparathyroidism","volume":"32","author":"Madkhali T","year":"2016","unstructured":"Madkhali T, Alhefdhi A, Chen H, Elfenbein D. Primary hyperparathyroidism. Ulus Cerrahi Derg. 2016, 32:58-66.","journal-title":"Ulus Cerrahi Derg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5146\/tjpath.2015.01316","article-title":"Parathyroid carcinoma: diagnosis and clinical implications","volume":"31 Suppl 1","author":"Duan K","year":"2015","unstructured":"Duan K, Mete \u00d6. Parathyroid carcinoma: diagnosis and clinical implications. Turk Patoloji Derg. 2015, 31 Suppl 1:80-97. 10.5146\/tjpath.2015.01316","journal-title":"Turk Patoloji Derg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas","volume":"21","author":"Kruijff S","year":"2014","unstructured":"Kruijff S, Sidhu SB, Sywak MS, Gill AJ, Delbridge LW. Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol. 2014, 21:426-33. 10.1245\/s10434-013-3288-8","journal-title":"Ann Surg Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102012","article-title":"Parathyroid cancer: an update","volume":"86","author":"Rodrigo JP","year":"2020","unstructured":"Rodrigo JP, Hernandez-Prera JC, Randolph GW, et al.. Parathyroid cancer: an update. Cancer Treat Rev. 2020, 86:102012. 10.1016\/j.ctrv.2020.102012","journal-title":"Cancer Treat Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4158\/EP11037.CRR","article-title":"Multiglandular parathyroid carcinoma: case report and review of the literature","volume":"17","author":"Haciyanli M","year":"2011","unstructured":"Haciyanli M, Oruk G, Ucarsoy AA, Gur O, Genc H. Multiglandular parathyroid carcinoma: case report and review of the literature. Endocr Pract. 2011, 17:e79-83. 10.4158\/EP11037.CRR","journal-title":"Endocr Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/214255-bisphosphonate-induced-orbital-cellulitis-in-a-patient-with-suspected-parathyroid-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T11:49:57Z","timestamp":1719834597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/214255-bisphosphonate-induced-orbital-cellulitis-in-a-patient-with-suspected-parathyroid-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.63577","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}